Review
doi: 10.1016/j.idc.2020.04.003.
Epub 2020 Sep 30.
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches
Affiliations
- PMID: 33011050
- DOI: 10.1016/j.idc.2020.04.003
Item in Clipboard
Review
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches
Infect Dis Clin North Am.
2020 Dec.
Abstract
Vancomycin and daptomycin are options for the initial treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Treatment options for persistent MRSA bacteremia or bacteremia due to vancomycin-intermediate or vancomycin-resistant strains include daptomycin, ceftaroline, and combination therapies. There is a critical need for high-level evidence from clinical trials to allow optimally informed decisions in the treatment of MRSA bacteremia.
Keywords: Bacteremia; Ceftaroline; Daptomycin; Endocarditis; MRSA; Methicillin; Staphylococcus aureus; Vancomycin.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.Infect Dis Clin North Am. 2016 Jun;30(2):491-507. doi: 10.1016/j.idc.2016.02.009. Infect Dis Clin North Am. 2016. PMID: 27208769 Review.
-
In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates.Microbiol Spectr. 2024 Aug 6;12(8):e0097624. doi: 10.1128/spectrum.00976-24. Epub 2024 Jun 25. Microbiol Spectr. 2024. PMID: 38916355 Free PMC article.
-
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.J Antimicrob Chemother. 2015 Jan;70(1):311-3. doi: 10.1093/jac/dku322. Epub 2014 Aug 13. J Antimicrob Chemother. 2015. PMID: 25125677 No abstract available.
-
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25. Int J Infect Dis. 2017. PMID: 28131729
-
Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant Staphylococcus aureus bloodstream infections: a case series and literature review.J Chemother. 2024 Nov;36(7):540-545. doi: 10.1080/1120009X.2024.2340877. Epub 2024 Apr 12. J Chemother. 2024. PMID: 38606836 Review.
Cited by
-
QKI degradation in macrophage by RNF6 protects mice from MRSA infection via enhancing PI3K p110β dependent autophagy.Cell Biosci. 2022 Sep 10;12(1):154. doi: 10.1186/s13578-022-00865-9. Cell Biosci. 2022. PMID: 36088389 Free PMC article.
-
Pharmacokinetic/Pharmacodynamic _target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections in Critically Ill Patients: Focus on Novel Infusion Mode.Front Cell Infect Microbiol. 2022 Jul 7;12:874401. doi: 10.3389/fcimb.2022.874401. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35873144 Free PMC article.
-
Rapid Monitoring of Vancomycin Concentration in Serum Using Europium (III) Chelate Nanoparticle-Based Lateral Flow Immunoassay.Front Chem. 2021 Oct 18;9:763686. doi: 10.3389/fchem.2021.763686. eCollection 2021. Front Chem. 2021. PMID: 34733823 Free PMC article.
-
β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium.Chem Rev. 2021 Mar 24;121(6):3412-3463. doi: 10.1021/acs.chemrev.0c01010. Epub 2020 Dec 29. Chem Rev. 2021. PMID: 33373523 Free PMC article. Review.
-
The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant Staphylococcus aureus.Antibiotics (Basel). 2021 Jan 20;10(2):96. doi: 10.3390/antibiotics10020096. Antibiotics (Basel). 2021. PMID: 33498191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
